Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
8,598 total articles
Telix Pharmaceuticals is threading multiple clinical and commercial catalysts into 2026: an FDA PDUFA for its glioma imaging agent, expanded clinical data for kidney imaging, low-toxicity dosimetry for its next-gen PSMA therapeutic, and a partnership with Regeneron that brings $40M up front plus sizable upside. With market cap at roughly $3.49B and…
McDonald's (MCD) combines durable franchise economics with optional upside from digital and AI-driven operating improvements. This trade idea looks for modest capital appreciation over a 180 trading day horizon while defending against margin pressure with a tight stop.
Parex Resources looks positioned to meaningfully re-rate as new development wells and infrastructure investments push production materially higher in the next 12 months. We initiate a strong buy with an entry at $8.50, a stop at $7.00 and a primary target of $12.00 over a 180 trading day horizon.
Monster delivered another solid quarter and continues to generate robust free cash flow and high returns on equity. That strength is already priced in: MNST trades near its 52-week high at ~ $88.55, with a P/E ~42 and EV/EBITDA ~30.8. Given stretched multiples, elevated RSI, and limited upside versus downside, we present a swing trade short with de…
Zscaler is trading off its 52-week highs but shows clear momentum and fundamental support as enterprises prioritize AI-safe cloud security. Strong free cash flow, accelerating technical momentum and a rising short-interest backdrop create a favorable asymmetric trade into earnings. This idea gives an entry at $177.21, a stop at $150.00 and a long-t…
Humana (HUM) slid after weak fiscal-2026 EPS guidance and membership softness, but the CMS 2027 Medicare Advantage capitation boost, solid cash flow, and an attractive enterprise multiple argue for a tactical buy on weakness. I upgrade to Buy with a clear entry, stop, and target for a swing/position trade over the next 45 trading days.
Starz has ripped higher from its February low but fundamentals and technicals still support further gains. The company trades below book, shows improving adjusted OIBDA after the spinoff, and carries elevated short interest that could amplify moves. We lay out a mid-term (45 trading days) long trade with an entry at $22.00, stop at $19.50 and a $28…
Alibaba is repositioning from a mature e-commerce cash machine into an AI infrastructure and cloud growth compounder. With cloud intelligence revenue growing 38% and adjusted EBITA up 57% recently, a $320B market cap and a P/E near 20, the stock looks set to re-rate if AI monetization continues. This trade proposes a controlled long with a $132.50 …
IREN has high-profile AI contracts that justify investor interest, but a costly transition to AI, negative free cash flow, a $2B convertible offering and very rich valuation create asymmetric downside in the near-to-mid term. We recommend a mid-term short with a clear entry, stop and target tied to operational and capital-marketing risk.
Service Corporation International (SCI) is a defensive, cash-generative play on North America's aging demographics and growing preference for cemetery-based revenue streams. At $78.62 today, SCI trades at roughly $10.9B market cap with a PE near 20 and EV/EBITDA ~11.9. For investors seeking income and low volatility exposure to deathcare services, …
Regeneron plunged after a Phase 3 fianlimab combination narrowly missed statistical significance for PFS (p=0.0627). The drop creates a tactical buying opportunity. The company still generates strong free cash flow, has low leverage, and multiple near-term catalysts. This trade idea grades REGN higher and lays out entry, stop, and target levels acr…
Mitsubishi UFJ Financial Group posted an earnings beat and is showing signs of return-on-equity expansion amid a higher-yield environment and a weakening yen. Valuation is reasonable (P/E ~13.3, P/B ~1.52) and technical momentum is constructive. We lay out a mid-term swing trade to capture further upside while keeping defined risk controls.
Robinhood has been punished for a crypto revenue slump and a near-term miss. That pain is priced in today around $76, but recent transaction gains in prediction markets, a 27.4 million funded customer base, and solid free cash flow create a favorable asymmetric trade. We upgrade to a tactical long with a mid-term plan to capture re-rating as the co…
Pitney Bowes (PBI) looks attractively positioned after a year of operating and cash-flow improvement. At ~$16.45 the stock trades at a modest multiple to earnings and strong free cash flow, yields a low-single-digit dividend, and has catalysts that could re-rate the multiple. This trade plan targets $20 over a 180-trading-day horizon with a $14 sto…
AppLovin reported consecutive quarters of high-teens-to-double-digit top-line growth and exceptionally strong operating leverage. With Q1 revenue accelerating to $1.84 billion (+59% YoY) and industry-leading adjusted margins, AppLovin is producing material free cash flow that is poorly reflected in the current narrative. This trade idea lays out a …
Applied Optoelectronics (AAOI) has been one of the poster children for the photonics/data-center trade. The stock is volatile and richly valued - but recent hyperscaler orders, a new Texas capacity build, and product wins give me enough conviction to keep a long position with a disciplined stop. This is an actionable trade idea with entry, stops, a…
Western Midstream (WES) offers an attractive ~8% yield backed by $1.34B in free cash flow, a $18B market cap and solid coverage metrics. The risk profile is real - leverage is elevated and the stock is near its 52-week high - but a disciplined entry, stop and target give a favorable risk-reward for a mid-term trade (45 trading days).
Array Technologies (ARRY) sits at an attractive entry after digesting acquisitions and capital raises. With a $1.33B market cap, positive free cash flow and valuation metrics that look reasonable for a recovery story, we expect ARR Y to swing back to profitability over the next several months. This trade outlines an entry, stop and target with mid-…
If Microsoft shifts away from an exclusive OpenAI-dependent playbook and accelerates proprietary model deployment and multi-partner integration, it can unlock clearer monetization paths for Copilot and Azure AI. The firm’s cash flow, low leverage, and strong profitability give it the balance sheet to absorb near-term investment for longer-term upsi…
AMD has the balance sheet strength, free cash flow, and product portfolio to capture a larger slice of the AI and data center pie. With momentum indicators bullish and valuation still digestible relative to its growth profile, this is a timely swing trade: buy at $422, risk-managed stop at $384, target $480 over a mid-term (45 trading days) horizon…
Meta's recent pullback has been treated like a structural problem by the market, but the company's cash generation, attractive cash-flow metrics, and reasonable leverage argue that the move is more of a short-term repricing than a durable reset. This trade idea outlines an actionable long with entry, stop and target, catalysts to watch, and the ris…
Pfizer is trading like a slow-growth utility while still generating near-$10B free cash flow, a 6.8% yield and trades at a mid-teens P/E. For investors willing to look past near-term patent headwinds, the risk/reward is compelling. This trade lays out an entry, stop and target for a long-term (180 trading days) swing that captures valuation reratin…
Astera Labs looks to be transitioning from high-volatility breakout to durable growth. The stock is trading above key moving averages, earnings power and free cash flow are real, and signal-integrity hardware remains a choke point in AI data centers. We lay out an actionable swing trade with entry, stop, and target plus catalysts and balanced risks…
NioCorp’s Elk Creek project is moving from resource to construction. A newly announced offtake agreement and the prospect of up to $800 million of project financing materially de-risks development funding. The market is pricing the company at about $780M — this trade hypothesis buys into near-term derisking and a re-rate if financing closes on cons…
Digi Power X (DGXX) is being upgraded to a tactical long after a strategic collaboration with Cerebras that accelerates its pivot into AI GPU/accelerator colocation. The company enters the trade with a cleaner balance sheet (>$30M cash + crypto holdings, no debt), positive adjusted EBITDA in Q2 2025, and market cap around $553M. Technicals show bul…
